Bill > HR7180

This bill, titled the "Countering Captagon and Narcotics Post-Assad Act," amends the National Defense Authorization Act for Fiscal Year 2023 to update an existing interagency strategy aimed at disrupting drug production and trafficking in the Middle East. Specifically, it recognizes that the shifting patterns of Captagon (a stimulant drug), methamphetamine, and amphetamine production and trafficking in the Middle East, especially after the potential fall of the Assad regime, pose a significant threat to regional stability and U.S. interests, requiring coordinated military and law enforcement action. The bill mandates that the strategy be unclassified and broadened from focusing solely on Syria to encompass the entire Middle East region. It requires the strategy to include an assessment of drug trafficking patterns within the area of responsibility of the United States Central Command, identifying countries receiving or transiting large shipments, evaluating their capacity to interdict these drugs, assessing current U.S. assistance programs, examining international cooperation, and providing recommendations to dismantle drug networks, including those linked to the former Assad regime, Hezbollah, and Iran-backed proxies.

Military Affairs and Security

https://www.congress.gov/bill/119th-congress/house-bill/7180/all-info